The use of stereotactic body radiotherapy (SBRT) as salvage therapy after radical prostatectomy was well tolerated, with no ...

For men who undergo a radical prostatectomy for the treatment of prostate cancer, post-surgery radiation therapy can play a ...

For men who undergo a radical prostatectomy for the treatment of prostate cancer, post-surgery radiation therapy can play a ...

Learn about the spit test that has shown promising results for detecting prostate cancer risk, proving to be more reliable ...

URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, has secured a new round of equity ...

Telix Pharmaceuticals excels in radiopharmaceuticals, with strong revenue growth driven by imaging products like Illuccix.

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant patients.

Once prostate cancer no longer responds to hormonal therapy, the cancer is called castration-resistant. Find out which ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both ...

UHF noninferior to conventionally fractionated radiotherapy for men with intermediate- to high-risk localized disease.

This study presents a valuable meta-analysis of two independent genome-wide association studies (GWASs) elucidating the role of plasma proteins as biomarkers for improving early detection of prostate ...